Global Novel Oral AntiCoagulants (NOAC) Market Research Report 2019

Table of Contents

Executive Summary

1 Novel Oral AntiCoagulants (NOAC) Market Overview

• 1.1 Product Overview and Scope of Novel Oral AntiCoagulants (NOAC)
• 1.2 Novel Oral AntiCoagulants (NOAC) Segment by Type
  • 1.2.1 Global Novel Oral AntiCoagulants (NOAC) Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Direct Thrombin Inhibitors
  • 1.2.3 Direct Factor Xa Inhibitors
• 1.3 Novel Oral AntiCoagulants (NOAC) Segment by Application
  • 1.3.1 Novel Oral AntiCoagulants (NOAC) Consumption Comparison by Application (2014-2025)
  • 1.3.2 Deep Vein Thrombosis (DVT)
  • 1.3.3 Pulmonary Embolism
  • 1.3.4 Acute Coronary Syndrome
  • 1.3.5 Hemodialysis
  • 1.3.6 Others
• 1.3 Global Novel Oral AntiCoagulants (NOAC) Market by Region
  • 1.3.1 Global Novel Oral AntiCoagulants (NOAC) Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Novel Oral AntiCoagulants (NOAC) Market Size
  • 1.4.1 Global Novel Oral AntiCoagulants (NOAC) Revenue (2014-2025)
  • 1.4.2 Global Novel Oral AntiCoagulants (NOAC) Production (2014-2025)

2 Global Novel Oral AntiCoagulants (NOAC) Market Competition by Manufacturers

• 2.1 Global Novel Oral AntiCoagulants (NOAC) Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Novel Oral AntiCoagulants (NOAC) Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Novel Oral AntiCoagulants (NOAC) Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Novel Oral AntiCoagulants (NOAC) Production Sites, Area Served, Product Types
• 2.5 Novel Oral AntiCoagulants (NOAC) Market Competitive Situation and Trends
  • 2.5.1 Novel Oral AntiCoagulants (NOAC) Market Concentration Rate
  • 2.5.2 Novel Oral AntiCoagulants (NOAC) Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Novel Oral AntiCoagulants (NOAC) Production Market Share by Regions

• 3.1 Global Novel Oral AntiCoagulants (NOAC) Production Market Share by Regions
• 3.2 Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Regions (2014-2019)
• 3.3 Global Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Novel Oral AntiCoagulants (NOAC) Production
  • 3.4.1 North America Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
  • 3.4.2 North America Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Novel Oral AntiCoagulants (NOAC) Production
  • 3.5.1 Europe Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
  • 3.5.2 Europe Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Novel Oral AntiCoagulants (NOAC) Production (2014-2019)
  • 3.6.1 China Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
  • 3.6.2 China Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Novel Oral AntiCoagulants (NOAC) Production (2014-2019)
  • 3.7.1 Japan Novel Oral AntiCoagulants (NOAC) Production Growth Rate (2014-2019)
  • 3.7.2 Japan Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Novel Oral AntiCoagulants (NOAC) Consumption by Regions

• 4.1 Global Novel Oral AntiCoagulants (NOAC) Consumption by Regions
• 4.2 North America Novel Oral AntiCoagulants (NOAC) Consumption (2014-2019)
• 4.3 Europe Novel Oral AntiCoagulants (NOAC) Consumption (2014-2019)
• 4.4 China Novel Oral AntiCoagulants (NOAC) Consumption (2014-2019)
• 4.5 Japan Novel Oral AntiCoagulants (NOAC) Consumption (2014-2019)

5 Global Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price Trend by Type

• 5.1 Global Novel Oral AntiCoagulants (NOAC) Production Market Share by Type (2014-2019)
• 5.2 Global Novel Oral AntiCoagulants (NOAC) Revenue Market Share by Type (2014-2019)
• 5.3 Global Novel Oral AntiCoagulants (NOAC) Price by Type (2014-2019)
• 5.4 Global Novel Oral AntiCoagulants (NOAC) Production Growth by Type (2014-2019)

6 Global Novel Oral AntiCoagulants (NOAC) Market Analysis by Applications

• 6.1 Global Novel Oral AntiCoagulants (NOAC) Consumption Market Share by Application (2014-2019)
• 6.2 Global Novel Oral AntiCoagulants (NOAC) Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Novel Oral AntiCoagulants (NOAC) Business

• 7.1 Johnson & Johnson
  • 7.1.1 Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
  • 7.1.2 Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
  • 7.1.3 Johnson & Johnson Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Bristol-Myers Squibb
  • 7.2.1 Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
  • 7.2.2 Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
  • 7.2.3 Bristol-Myers Squibb Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Boehringer Ingelheim
  • 7.3.1 Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
  • 7.3.2 Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
  • 7.3.3 Boehringer Ingelheim Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Sanofi
  • 7.4.1 Sanofi Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
  • 7.4.2 Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
  • 7.4.3 Sanofi Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Daiichi Sankyo
  • 7.5.1 Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
  • 7.5.2 Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
  • 7.5.3 Daiichi Sankyo Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Armatheon
  • 7.6.1 Armatheon Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
  • 7.6.2 Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
  • 7.6.3 Armatheon Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Aspen
  • 7.7.1 Aspen Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
  • 7.7.2 Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
  • 7.7.3 Aspen Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 AstraZeneca
  • 7.8.1 AstraZeneca Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
  • 7.8.2 Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
  • 7.8.3 AstraZeneca Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Bayer
  • 7.9.1 Bayer Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
  • 7.9.2 Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
  • 7.9.3 Bayer Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Cellceutix
  • 7.10.1 Cellceutix Novel Oral AntiCoagulants (NOAC) Production Sites and Area Served
  • 7.10.2 Novel Oral AntiCoagulants (NOAC) Product Introduction, Application and Specification
  • 7.10.3 Cellceutix Novel Oral AntiCoagulants (NOAC) Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Cosmo Pharmaceuticals
• 7.12 CSL Behring
• 7.13 Eisai
• 7.14 GSK
• 7.15 Marathon Pharmaceuticals
• 7.16 Ockham Biotech
• 7.17 Perosphere

8 Novel Oral AntiCoagulants (NOAC) Manufacturing Cost Analysis

• 8.1 Novel Oral AntiCoagulants (NOAC) Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Novel Oral AntiCoagulants (NOAC)
• 8.4 Novel Oral AntiCoagulants (NOAC) Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Novel Oral AntiCoagulants (NOAC) Distributors List
• 9.3 Novel Oral AntiCoagulants (NOAC) Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Novel Oral AntiCoagulants (NOAC) Market Forecast

• 11.1 Global Novel Oral AntiCoagulants (NOAC) Production, Revenue Forecast
  • 11.1.1 Global Novel Oral AntiCoagulants (NOAC) Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Novel Oral AntiCoagulants (NOAC) Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Novel Oral AntiCoagulants (NOAC) Price and Trend Forecast (2019-2025)
• 11.2 Global Novel Oral AntiCoagulants (NOAC) Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Novel Oral AntiCoagulants (NOAC) Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Novel Oral AntiCoagulants (NOAC) Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Novel Oral AntiCoagulants (NOAC) Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Novel Oral AntiCoagulants (NOAC) Production, Revenue Forecast (2019-2025)
• 11.3 Global Novel Oral AntiCoagulants (NOAC) Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Novel Oral AntiCoagulants (NOAC) Consumption Forecast (2019-2025)
  • 11.3.2 Europe Novel Oral AntiCoagulants (NOAC) Consumption Forecast (2019-2025)
  • 11.3.3 China Novel Oral AntiCoagulants (NOAC) Consumption Forecast (2019-2025)
  • 11.3.4 Japan Novel Oral AntiCoagulants (NOAC) Consumption Forecast (2019-2025)
• 11.4 Global Novel Oral AntiCoagulants (NOAC) Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Novel Oral AntiCoagulants (NOAC) Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List